Peptide-based immunotherapeutic agent

Details Peptide-based immunotherapeutic agent Peptide-based immunotherapeutic agent

2006-04-11

2006-04-11

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S275100, C530S326000

Reexamination Certificate

active

07025964

ABSTRACT:
A peptide-based immunotherapeutic agent effective for every allergy patient is provided. A reagent for typing HLA class II molecules of the patient to be used in selecting a peptide-based immunotherapeutic agent effective for every allergy patient is also provided. The peptide-based immunotherapeutic agent enables the optimal peptide-based immunotherapy for each patient, so that a marked improvement in peptide-immunotherapy can be expected. The peptide-based immunotherapeutic agent is also effective for patients who cannot be treated by peptide-based immunotherapy using major antigen peptide recognized in a particular patient population. Furthermore, the peptide-based immunotherapeutic agent enables simple and easy typing of HLA class II molecules of allergy patients.

REFERENCES:
patent: 0432691 (1991-06-01), None
patent: 0700929 (1996-03-01), None
patent: 0700929 (1996-03-01), None
patent: 7-118295 (1995-05-01), None
patent: 8-047392 (1996-02-01), None
patent: 8-333391 (1996-12-01), None
patent: WO 93/01213 (1993-01-01), None
patent: WO 93/08279 (1993-04-01), None
patent: WO 94/01560 (1994-01-01), None
patent: WO 94/11738 (1994-05-01), None
patent: WO 94/16068 (1994-07-01), None
patent: WO 97/32600 (1997-09-01), None
Hashiguchi et al. Molecular immunology of Japanese cedar pollen allergens: analysis of T cell epitopes, Aug. 1996, Nippon Rinsho 54(8): 2233-42.
Hori et al, Janpanese cedar pollinosis and HLA-DP5, Jun. 1996, Tissue Antigens 47(6): 485-91.
Hoyne et al, Immunology and Cell Biology 74: 180-186, 1996.
Briner et al., Peripheral T-cell tolerance included in naïve and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I, Proc. Natl. Acad. Sci. USA 90:7608-7612, Aug. 1993.
O'Hehir et al., “The Specificity and Regulation of T-Cell Responsiveness to Allergens,” Annu. Rev. Immunol. 9:67-95, 1991.
Rogers et al., “Potential Therapeutic Recombinant Proteins Comprised of Peptides Containing Recombined T Cell Epitopes,” Molecular Immunology 31(13): 955-966, 1994.
Higgins et al., “Overlapping T-cell epitopes in the group 1 allergen of Dermatophagoides species restricted by HLA-DP and HLA-Dr class II molecules,” J Allergy Clin. Immunol. 93:891-9, 1994.
Matsunaga et al., “Participation of cathepsin B in processing of antigen presentation to MHC class II,” FEBS Letters 324(3):325-330, 1993.
Ishikawa et al., “Human T. Cell Response to Antigen Peptides of Japanese Cedar Pollen (Cry j l),” Int. Arch. Allergy Immunol. 113:255-257, 1997.
Dodson, “Counting dinosaurs: How many kinds were there?,” Proc. Natl. Acad. Sci., USA, 87: 7608-7612, 1990.
Hashimoto et al., “Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis,” Clinical and Experimental Allergy 25:848-852, 1995.
Hori et al., “Japanese cedar pollinosis and HLA-DP5,” Tissue Antigens 47:485-491, 1996.
Ikagawa et al., “Allergens, IgE, mediators, inflammatory mechanisms—Single amino acid substitutions . . . antagonism,” J. Allergy Clin. Immunol. 97:53-64, 1996.
June et al., “The B7 and CD28 receptor families,” Immunology Today 15(7):321-331, 1994.
Komiyama et al., “cDNA cloning and Expression of Cry j II, the Second Major Allergen of Japanese Cedar Pollen,” Biochemical and Biophysical Research Communications 201(2):1021-1028, 1994.
Matsushita et al., “Allele Specificity of Structural Requirement for Peptides Bound to HLA-DRB1*0405 and -DRB1*0406 Complexes . . . Syndrome,” J. Exp. Med. 180:873-883, 1994.
Rammensee et al., “MHC ligands and peptide motifs: first listing,” Immunogenetics 41:178-228, 1995.
Sasazuki et al. inDNA Component, vol. 1, pp. 395-518, 1982.
Yasueda et al., “Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen,” J. Allergy Clin. Immunol. 71(No. 1, Part 1):77-86, 1983.

Affiliated with

Also associated with

Rating

Peptide-based immunotherapeutic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-based immunotherapeutic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-based immunotherapeutic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3577825